Influence of Patents on Embryonic Stem Cells Research
Journal of Advances in Medical and Pharmaceutical Sciences,
This article mainly examines stem cells related patents. We first provided a general background on patents. Then, we investigated patents and how they influence innovation in general, and stem cells in particular. Challenges to patenting inventions and innovations associated with stem cells’ field of study in the US and Europe are provided.
- Patent system
- new drugs
- stem cells
- influence innovation
How to Cite
Allred BB, Park WG: The influence of patent protection on firm innovation investment in manufacturing industries. Journal of International Management 2007, 13(2):91-109.
Lincoln A: Second Lecture on Discoveries and Inventions; 1859.
Encaoua D, Guellec D, Martnez C: Patent systems for encouraging innovation: Lessons from economic analysis. Research Policy, 2006;35(9):1423-1440.
Erkal N: The decision to patent, cumulative innovation, and optimal policy. International Journal of Industrial Organization. 2005;23(7-8):535-562.
Llobet G: Patent litigation when innovation is cumulative. International Journal of Industrial Organization. 2003;21(8):1135-1157.
Macdonald S: When means become ends: considering the impact of patent strategy on innovation. Information Economics and Policy. 2004; 16(1):135-158.
Ramsey G: The Historical Background of Patents. Journal of the Patent Office Society. 1936;18:6.
Adams S: Centenary of the enactment of the United Kingdom's Patents and Designs Act 1907. World Patent Information. 2007; 29(4):363-368.
Mokyr J: The Industrial Revolution and the economic history of technology: Lessons from the British experience, 1760-1850[small star, filled]. The Quarterly Review of Economics and Finance. 2001; 41(3):295-311.
Acs ZJ, Anselin L, Varga A: Patents and innovation counts as measures of regional production of new knowledge. Research Policy. 2002;31(7):1069-1085.
Jalles JT: How to measure innovation? New evidence of the technology-growth linkage. Research in Economics. 64(2): 81-96.
Lindsay J, Jiao X, Sakamaki T, Casimiro MC, Shirley LA, Tran TH, Ju X, Liu M, Li Z, Wang C: ErbB2 Induces Notch1 Activity and Function in Breast Cancer Cells; 2008.
Chen Q: The effect of patent laws on invention rates: Evidence from cross-country panels. Journal of Comparative Economics. 2008;36(4):694-704.
Caulfield T, Gold ER, Cho MK: Patenting human genetic material: refocusing the debate. Nature Reviews Genetics. 2000;1(3):227-231.
GlaxoSmithKline: Intellectual Property and Access to Medicines in Developing Countries.
Available:http://www.gsk.com/policies/GSK-on-IP-and-access-to-medicines-in-developing-countries.pdf. . September 2007, access date 1 November 2010.
The L: Global HIV/AIDS estimates--looking beyond the numbers. The Lancet. 2008, 370(9602):1802-1802.
Hardin G: The Tragedy of the Commons. Science. 1968;162(3859):1243-1248.
Parisi F, Schulz N, Depoorter B: Duality in Property: Commons and Anticommons. International Review of Law and Economics. 2005;25(4):578-591.
Murray F, Stern S: Do formal intellectual property rights hinder the free flow of scientific knowledge?: An empirical test of the anti-commons hypothesis. Journal of Economic Behavior & Organization. 2007;63(4):648-687.
Sim L-L, Lum S-K, Malone-Lee LC: Property rights, collective sales and government intervention: averting a tragedy of the anticommons. Habitat International. 2002;26(4):457-470.
Heller MA: The tragedy of the anticommons: Property in the transition from Marx to markets. Harvard Law Review, 1998;111(3):621-688.
Mause K: The Tragedy of the Commune: Learning from worst-case scenarios. Journal of Socio-Economics. 2008;37(1):308-327.
Kitch EW, Kieff FS: Comment on the Tragedy of the Anticommons in Biomedical Research. In: Advances in Genetics. vol. Volume 50: Academic Press. 2003;271-273.
Thumm N: Patents for genetic inventions: a tool to promote technological advance or a limitation for upstream inventions? Technovation. 2005;25(12):1410-1417.
Ebersole TJ. et al. Stem cells — patent pools to the rescue? (Sterne, Kessler, Goldstein, & Fox P.L.L.C., Washington, DC; 2005.
Rohrbaugh, M.L. in Regenerative Medicine 2006 (National Institutes of Health, Washington, DC; 2006.
Jaffe AB, Lerner J. Innovation and Its Discontents: How Our Broken Patent System is Endangering Innovation and Progress, and What to Do About It (Princeton University Press, Princeton, New Jersey, USA; 2004.
Rai AK. Eisenberg, R.S. Law Contemp. Probl. 2003;289:289–314.
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic Stem Cell Lines Derived from Human Blastocysts. Science. 1998;282(5391):1145-1147.
Kahn M: European agency rules against stem cell patents. Reuters 2008,
Accessed December 15-2010
Karlsson U, Hyllner J, Runeberg K: Trends in the human embryonic stem cell patent field. Recent Patents on Nanotechnology. 2007;1(3):233-7.
Accessed December 22-2010
Keegan KD: Biotechnology valuation: an introductory guide. England: John Wiley and Sons; 2008.
McCartney JJ: Embryonic stem cell research and respect for human life: philosophical and legal reflections. Albany Law Rev. 2002;65(3):597-624.
Resnik DB: Embryonic stem cell patents and human dignity. Health Care Analysis. 2007;15:211-222.
Plomer A, Taymor KS, Scott CT: Challenges to human embryonic stem cell patents. Cell Stem Cell. 2008;2(1):13-17.
Johnston J: US Stem Cell Research Policy. In: Principles of Regenerative Medicine. San Diego: Academic Press. 2008:1354-1365.
Winickoff DE: Governing stem cell research in California and the USA: towards a social infrastructure. Trends in Biotechnology. 2006;24(9):390-394.
Holden C: Stem cells - Prominent researchers join the attack on stem cell patents. Science. 2007;317(5835):187-187.
Gawrylewski A: USPTO upholds Stem Cell Patent.
Available: http://www.the-scientist.com/blog/display/54389. 28th February 2008 access date October 2010.
John M. Simpson, USPTO Rejects WARF's Stem Cell Patent Claims; 2010.
Stuart JH, Graham BHH, Dietmar Harhoff, David C. Mowery: Post-Issue Patent "Quality Control": A Comparative Study of US Patent Re-examinations and European Patent Oppositions. National Bureau of Economic Research; 2002.
Waltz E: Industry waits for fallout from Cabilly. Nature Biotechnology. 2007;25(7):699-700.
Waltz E: Genentech's Cabilly victory. Nature Biotechnology. 2009;27(4):307-307.
consumer watchdog: Upholding of WARF Stem Cell Patent Reversed; 2010.
Available:http://www.consumerwatchdog.org/patients/articles//?storyId=34079&bIndex=70 May 03, 2010 access date 7 October.
Geron Corporation: Geron Comments on Decision by U.S. PTO on WARF Patent; 2010.
Available:http://www.geron.com/media/pressview.aspx?id=1219. 2010, access date 19 October.
The European Parliament and Council: Directive on the legal protection of biotechnological inventions (Directive 98/44/EC); 1998.
Salter B: Patenting, morality and human embryonic stem cell science: bioethics and cultural politics in Europe. Regenerative Medicine. 2007;2(3): 301-311.
Fitt R: New guidance on the patentability of embryonic stem cell patents in Europe. Nature Biotechnology. 2009;27(4): 338-340.
Bahadur G, Morrison M: Patenting human pluripotent cells: balancing commercial, academic and ethical interests. Human Reproduction. 2010;25(1):14-21.
Aurora polmer, Chris Denning, Bartha Knoppers, Marianne Levin, John Sinden, Torremans P: Stem Cell Patents: European Patent Law and Ethics Report;2004.
Orive G, Hernلndez RM, Gascَn AR, Igartua M, Pedraz JL: Controversies over stem cell research. Trends in Biotechnology. 2003;21(3):109-112.
Smith A, Mountford P, Munsie M: Process for obtaining stem cells, WO/1999/055841. In. Edited by World Intellectual Property Organization, PCT/GB1999/001333 edn: University of Edinburgh; 1999.
United Kingdom Intellectual Property Office: Inventions involving human embryonic stem cells; 2009.
Available: http://www.ipo.gov.uk/pro-types/pro-patent/p-law/p-pn/p-pn-stemcells-20090203.htm., access date 2 November 2010.
United Kingdom Intellectual Property Office: Patentability of human embryonic stem cells: WARF's European patent application:
Available: http://www.ipo.gov.uk/p-policy-biotech-stemcell.htm. 2008, access date 9 November.
Oliver Brüstle: DE 197 56 864 C1. In. Edited by German Patent Office;1999.
Abbott A: Fresh hope for German stem-cell patent case; 2009.
Genetics and Patenting: Genetics and Patenting: Human Genome Project Information; 2010. Available:
Abstract View: 55 times
PDF Download: 17 times